StockNews.com Initiates Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report issued on Saturday. The brokerage issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

Shares of NYSE AMPE opened at $0.00 on Friday. The firm has a market cap of $2,394.00, a PE ratio of 0.00 and a beta of 2.21. Ampio Pharmaceuticals has a 1-year low of $0.00 and a 1-year high of $7.47. The company has a fifty day moving average price of $0.12 and a 200 day moving average price of $0.79.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.